Psoriatic Arthritis News

Tildrakizumab was associated with strong PASI90 and ACR20 results compared with placebo in a cohort of patients with psoriatic arthritis, according to recent findings presented at the EULAR Annual Congress.

Registry data from four European countries found no association between treatment with TNF inhibitors for psoriatic arthritis and an overall increase in cancer risk, according to findings presented at the EULAR Annual Congress.

Ixekizumab was associated with superior efficacy outcomes compared to adalimumab in a cohort of DMARD-naive patients with active psoriatic arthritis, according to findings presented at the EULAR Annual Congress.

Researchers working in clinical trials for psoriasis should standardize the use of psoriatic arthritis screening tools in all patients, according to recommendations based on an online survey and consensus meeting results organized by the International Dermatology Outcomes Measures initiative.

Amgen is currently embroiled in two pivotal court cases surrounding patents for its bestselling etanercept product that could protect it from competition in the United States for another decade.

Etanercept is well-tolerated and safe for up to 6 years in patients with extended oligoarticular juvenile idiopathic arthritis, psoriatic arthritis and enthesitis-related arthritis, according to data published in Arthritis Research & Therapy.

Although rheumatologists overwhelmingly agree on the use of conventional synthetic DMARDs and biologic drugs for inflammatory arthritis in patients with planned pregnancies, there appears to be little consensus on when to suspend drugs and how to handle unplanned pregnancies, according to survey data in BMC Rheumatology.

Costs for the 49 top-selling brand-name prescription drugs in the United States increased by a median 76% between 2012 and 2017, with all but one drug displaying regular annual or biannual price increases, according to an analysis of pharmacy claims data published in JAMA Network Open.

Fear and anxiety related to their disease, in addition to infertility, may impact family sizes of women with inflammatory arthritis, according to data published in ACR Open Rheumatology.

In the ever-changing landscape of the United States health care system, rheumatologists need a voice. They need a voice in managing the complex web of drug pricing structures, a voice in developing clinical guidelines, and, on a fundamental level, a voice in simply communicating with all the players involved in running the day-to-day operations of a rheumatology practice.